These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization. Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab. Yang HS; Kim JG; Kim JT; Joe SG Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study. Chan WM; Lai TY; Liu DT; Lam DS Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414 [TBL] [Abstract][Full Text] [Related]
12. Multiple Choroidal Neovascularizations in Choroidal Osteoma Treated with Anti-VEGF Injections: A 6-Year Follow-Up Case Report. Xuan Y; Wang M Retin Cases Brief Rep; 2024 Mar; ():. PubMed ID: 38442419 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters. Chang YS; Kim JH; Kim JW; Lee TG; Kim CG Korean J Ophthalmol; 2016 Aug; 30(4):272-9. PubMed ID: 27478354 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal Bevacizumab for Nonsubfoveal Choroidal Neovascularization Associated With Angioid Streaks: 3-Year Follow-up Study. Iacono P; Battaglia Parodi M; La Spina C; Bandello F Am J Ophthalmol; 2016 May; 165():174-8. PubMed ID: 27013066 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment of choroidal neovascularization complicating a choroidal osteoma with intravitreal bevacizumab. Rao S; Gentile RC Retin Cases Brief Rep; 2010; 4(4):303-5. PubMed ID: 25390904 [TBL] [Abstract][Full Text] [Related]
17. Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma. Wu ZH; Wong MY; Lai TY Case Rep Ophthalmol; 2012 May; 3(2):200-4. PubMed ID: 22740831 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization. Lai TY; Luk FO; Lee GK; Lam DS Eye (Lond); 2012 Jul; 26(7):1004-11. PubMed ID: 22595908 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal ranibizumab for the treatment of pathological myopia associated with choroidal neovascularization in Chinese patients. Yang X; Dai H Chin Med J (Engl); 2014; 127(16):2906-10. PubMed ID: 25131225 [TBL] [Abstract][Full Text] [Related]
20. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization. Ahn SJ; Park KH; Woo SJ Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]